The Patent Finder

Cydex Pharmaceuticals, Inc.

41 patents currently held · Updated Nov 15, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
25
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 18, 2026
    The maintenance fee for Alkylated cyclodextrin compositions and processes for preparing and using the same (US 10,323,103) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
  • 1 fee due Mar 8, 2027
    The maintenance fee for Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use (US 9,125,945) comes due Mar 8, 2027. Unpaid by Sep 8, 2027, it lapses early.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same (US 11,795,241) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
  • 2 fees due May 5 to 7, 2027 · next May 5
  • 2 fees due Jun 1 to 24, 2027 · next Jun 1
  • 1 fee due Oct 28, 2027
    The maintenance fee for Manufacturing process for cyclodextrin derivatives (US 10,633,462) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,846,901Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,049,003Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,668,160DPI formulation containing sulfoalkyl ether cyclodextrin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,370,352Nasal and ophthalmic delivery of aqueous corticosteroid solutions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,114,438Dpi Formulation Containing Sulfoalkyl Ether Cyclodextrin
In force
 · Low confidence
In forceLow confidence
US 8,853,236Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,125,945Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,623,045Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,034,947Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,512,697Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 41 patents shown.
Pro members see all 41.
Pro members: see all 41 patents
Also on record, not counted in the 41: 3 patents in force now held by others · 17 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 3 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited